Department of Orthopedic and Trauma Surgery, University Medical Center Mannheim, Mannheim, Germany.
Int Orthop. 2012 Jun;36(6):1255-60. doi: 10.1007/s00264-011-1470-9. Epub 2012 Jan 22.
To evaluate whether this new method is clinically applicable after theoretical and cadaver testing.
The incidence of spinal metastases requiring therapy is increasing, due to enhanced life expectancy. Due to results from studies with epidural compression a combined surgical and radiation therapy is often chosen. Minimal invasive cement augmentation is an increasingly used technique, due to fast pain relief and immediate stabilisation. On the other hand, stereotactic radiosurgery is considered to provide a more durable response and better local disease control than conventional radiotherapy with the application of higher doses. Therefore the combination of cement stabilisation and simultaneous intra-operative radiation with immediate stabilisation and high-dose radiation could be an interesting therapeutic option. The results of a clinical feasibility study are presented.
17 patients could be treated with the new method. In two patients (10%) intra-operative radiation could not be applied. No surgical interventions for complications were required.
Summarizing Kypho-IORT is technically feasible with an intra-operative risk profile comparable to sole kyphoplasty and a shorter treatment time and hospitalisation for the patients compared to conventional multifraction radiation. Radiation could not be applied in 10% of cases due to technical difficulties. The results of this feasibility study permit further evaluation of this new technique by a dose escalation study which is currently in preparation.
在理论和尸体测试后评估新方法是否具有临床适用性。
由于预期寿命的延长,需要治疗的脊柱转移发生率正在增加。由于硬膜外压迫的研究结果,通常选择联合手术和放射治疗。微创水泥增强术是一种越来越常用的技术,因为它可以快速缓解疼痛并立即稳定。另一方面,立体定向放射外科被认为比常规放射治疗具有更高剂量的应用能提供更持久的反应和更好的局部疾病控制。因此,水泥稳定与术中放疗相结合,立即稳定和高剂量放疗可能是一种有趣的治疗选择。介绍了一项临床可行性研究的结果。
17 例患者可采用新方法治疗。在 2 例患者(10%)中无法进行术中放疗。无需进行手术干预以处理并发症。
总结而言,与单纯的椎体后凸成形术相比,经皮椎体成形术中内放疗(Kypho-IORT)具有技术可行性,且患者的治疗时间和住院时间更短,但由于技术困难,10%的病例无法进行放疗。这项可行性研究的结果允许通过目前正在准备的剂量递增研究进一步评估这项新技术。